| Aramchol (aramchol meglumine) / Galmed |
2019-002073-56: A study to investigate the efficacy and safety of Aramchol in patients with a form of fatty liver disease. |
|
|
| Not yet recruiting | 3/4 | 2000 | Europe | Aramchol, Tablet | Galmed Research and Development, Ltd., Galmed Research and Development, Ltd. | Nonalcoholic Steatohepatitis (NASH), NASH is a chronic liver disease caused by the build-up of too much fat in the liver, along with inflammation and liver damage., Diseases [C] - Digestive System Diseases [C06] | | | | |
NCT06095986: A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis |
|
|
| Suspended | 2 | 24 | US | Aramchol meglumine | Galmed Pharmaceuticals Ltd, Virginia Commonwealth University | Primary Sclerosing Cholangitis | 09/26 | 12/27 | | |
NCT05874336: An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol |
|
|
| Completed | 1 | 6 | Europe | Aramchol, Aramchol free acid (3β-arachidylamido-7α,12α-dihydroxy-5β-cholan-24-oic acid) | Galmed Pharmaceuticals Ltd, Quotient Sciences | NASH | 08/20 | 08/20 | | |
NCT04480827: Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment |
|
|
| Completed | 1 | 57 | US | Aramchol free acid tablet 600mg, single dose, Cholan-24-oic acid 7,12-dihydroxy3-[(1- oxoeicosyl)amino]-(3β,5β,7α,12α) salt with N-methyl-(D)-glucamine, Aramchol free acid tablet 300mg, bid | Galmed Research and Development, Ltd. | Hepatic Impairment | 03/22 | 03/22 | | |
NCT06502561: Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets |
|
|
| Not yet recruiting | 1 | 16 | Europe | Aramchol meglumine, Cholan-24-oic acid 7,12-dihydroxy3-[(1-oxoeicosyl)amino]-(3β,5β,7α,12α) salt with N-methyl-(D)-glucamine-Aramchol Meglumine, Aramchol free acid, 3β-arachidylamido-7α,12α-dihydroxy-5β-cholan-24-oic acid | Galmed Pharmaceuticals Ltd | Healthy | 01/25 | 04/25 | | |
| Undisclosed CTLA4 inhibitor antibody therapeutic / Tikcro Technologies |
| No trials found |
| anti-TIGIT antibody / Tikcro Technologies |
| No trials found |
| anti-PD-1 antibody / Tikcro Technologies |
| No trials found |
| Undisclosed anti-PD-L1 antibody / Tikcro Technologies |
| No trials found |
| AAV-Gcase D15 / Lysogene |
| No trials found |
